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Abstract
Background: The nucleosome binding protein 1 (HMGN5/NSBP1) is a member of the HMGN protein family and is
highly expressed in several kinds of cancer. Nevertheless, the role of NSBP1 in clear cell renal cell carcinoma
(ccRCC) remains unclear. This study aimed to confirm the oncogenic role of NSBP1 in ccRCC using in vitro and in
vivo models and explore the mechanism by which NSBP1 contributes to ccRCC tumorigenesis.
Methods: NSBP1 expression was detected in renal tissues from 152 ccRCC patients by immunohistochemistry, and
examined in ccRCC cell lines by RT-PCR and Western blot analysis. ccRCC cells were transfected by NSBP1 RNAi
and cell viability, apoptosis and invasion were detected by cell vitality test, flow cytometry and transwell assay in
vitro. Xenograft in nude mice was also employed to examine the tumorigenesis of ccRCC cells depleted of NSBP1.
Results: Immunohistostaining showed strong immunoreactivity of NSBP1 in all ccRCC tissues and NSBP1
expression level was associated with tumor grade (p = 0.04). NSBP1 expression at mRNA and protein levels was
high in ccRCC cell lines. Knockdown of NSBP1 induced cell cycle arrest and apoptosis, and inhibited invasion in
786-O cells. Western blot analysis demonstrated increased expression of Bax and decreased expression of Bcl-2,
CyclinB1, VEGF, VEGFR-2, MMP-2, MMP-9, c-fos and c-jun in 786-O cells depleted of NSBP1. In vivo study further
showed that knockdown of NSBP1 affected the tumorigenesis of ccRCC cells in nude mice.
Conclusions: NSBP1 plays oncogenic role in ccRCCs by promoting cell proliferation and invasion, and could be
exploited as a target for ccRCC treatment.
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Introduction
Renal carcinoma is the 13th most common cancer
worldwide, with clear cell and clear cell renal cell carci-
noma (ccRCC) accounting for most of the renal cell car-
cinoma (RCC) [1]. Radical nephrectomy is effective to
cure early and local ccRCCs, but advanced or metastatic
ccRCCs barely respond to chemotherapy or radiotherapy
and have poor prognosis. Therefore, it is important to
better understand the pathogenesis of aggressive RCC in
order to develop effective strategies for the prevention
and treatment of RCC.
NSBP1 is a new member of the high mobility group N
(HMGN) protein family that modulates the structure
and function of chromatin and plays an important role
in transcription, histone modifications, DNA replication
and DNA repair in living cells[2]. Early study showed
that nucleosome binding protein 1 (HMGN5/NSBP1)
was abundantly expressed in prostate cancer [3]. In
addition, NSBP1 expression was upregulated in squa-
mous cell carcinoma, metastatic MDA-MB-435HM
breast cancer cell line and adenocarcinoma, suggesting
that NSBP1 may promote tumorigenesis [4-7].
Our previous studies showed that downregulation of
NSBP1 expression caused G2 cell cycle arrest, decreased
proliferation rate and increased apoptosis rate in pros-
tate cancer cells in vitro [8,9]. Nevertheless, the role of
NSBP1 in ccRCC development remains unknown.
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cesses, among which proteolytic degradation of extracel-
lular matrix (ECM) and angiogenesis (VEGF) are
essential steps. ECM degradation can be promoted by
the imbalance between proteolytic proteases and their
inhibitors. Extensive studies have shown that matrix
metalloproteinases (MMPs) play crucial role in the
degradation of ECM to promote tumor invasion and
metastasis [10,11].
Therefore, in this study we investigated the role of
NSBP1 in ccRCC. First we detected NSBP1 expression
in clinical ccRCC tissues and ccRCC cell lines. Then we
examined the effects of lentivirus mediated NSBP1
knockdown on the growth and invasion of ccRCC 786-
O cells and xenograft tumor growth in nude mice. The
results showed that NSBP1 expression was upregulated
in ccRCC tissues and ccRCC cell lines, and NSBP1
knockdown could induce apoptosis and inhibit the pro-
liferation and invasion of ccRCC cells, and further
decrease ccRCC tumor growth in nude mice.
Methods
Clinical samples
A total of 152 patients (aged 52 to 90 years old, median
age of 64 years) who underwent surgery from January
2008 to January 2011 in Peking University First Hospital
were enrolled in the present study. All patients were of
Chinese origin. Paraffin wax-embedded blocks of tumor
tissues from each patient were assembled from the
archival collections at the Department of Pathology. Sur-
vival data of all patients were collected. Among these
patients, 20 patients were randomly selected and paired
cancer and adjacent tissues were collected from them
for Western blot analysis of NSBP1 expression. All adja-
cent tissues were confirmed to be normal by experi-
enced pathologists. The protocols for the present study
were approved by the Ethics Committee of Peking Uni-
versity First Hospital.
Cell culture
The ccRCC cell lines Caki-2, A498, 786-O and the nor-
mal renal tubular epithelial line HK-2 were purchased
from American Type Culture Collection (ATCC, Mana-
ssas, VA). HK-2 cells were cultured in K-SFM medium
(Gibco™ Life Technologies, Grand Island, NY), and
other cells were cultured in RPIM-1640 (HyClone,
Logan, UT) medium supplemented with 10% Gibco™
F B S( L i f eT e c h n o l o g i e s ,G r a n dI s l a n d ,N Y ) .A l lc e l l s
were cultured at 37°C in a standard humidified incuba-
tor containing 5% CO2 and 95% O2.
Lentivirus RNAi construct and transfection
The siRNA targeting the human NSBP1 (NM_030763)
transcript was designed using the software developed by
Ambion (Foster, CA, USA) with the following sequence:
PscSI616 CACAGCCTTTCTTTAGCATTTCAAGA-
GAATGCTAAAGAAAGG-CTGTG/CACAGCCTTTC
TTTAGCATTCTCTTGAAATGCTAAAGA-AAGGC
TGTG. NSBP1 siRNA or control scramble siRNA was
cloned into vector. 786-O cells were seeded onto 6-well
plates and grown to 60% confluence on the day of trans-
fection. 4 h before transfection, cells were placed in
serum-free media. Cells were transfected with 100 nM
siRNA vector diluted in RPMI-1640 according to the
manufacturer’s protocol. Successful knockdown of
NSBP1 was analyzed by Western blot analysis and real-
time PCR.
Immunohistochemistry
Paraffin-embedded tissues were cut into 4 um-thick
consecutive sections and were then dewaxed in xylene
and rehydrated in graded ethanol solutions. Antigen
retrieval was performed following the standard proce-
dure. Sections were cooled and immersed in a 0.3%
hydrogen peroxide solution for 15 min to block endo-
genous peroxidase activity, and then rinsed in PBS for 5
min. Non-specific labeling was blocked by incubation
with 5% bovine serum albumin at room temperature for
30 min. Sections were then incubated with primary rab-
bit anti-human antibody against NSBP1 (diluted in
1:100, Abcam, ab56031, Cambridge, MA) at 4°C over-
night, rinsed with PBST, incubated with horseradish
peroxidase-conjugated Santa Cruz™ goat anti-rabbit
IgG secondary antibody (Santa Cruz, CA), developed by
peroxidase-conjugated streptavidin and DAB, and coun-
terstained by hematoxylin. All slides were examined
independently by two pathologists, who were not
informed about patients’ clinical data. Specimens were
then grouped according to stage (T1-T4) and specific
staining intensity. The staining intensity was scored as
“-” for negative, “+” for moderate, and “++” for strong
staining.
Quantitative real-time PCR assay
Total RNA was extracted from the cells using Trizol
(Invitrogen) according to the manufacturer’sp r o t o c o l .
First-strand cDNA was generated using 2 μgt o t a lR N A
via MMLV-reverse transcriptase using High Capacity
RNA-to-cDNA kit (Promega) with random primers. A
final reaction of 20 ul was used to determine the mRNA
level by real-time PCR using an ABI Prism 7300
(Applied Biosystems, Foster City, CA, USA). The speci-
fic primers were as follows: NSBP1, 5’-TCGGCT
TTTTTTCTGCTGACTAA-3’(forward) and 5’-CTC
TTTGGCTCCTGCCTCAT-3’(reverse); Actin, 5’-GTG
GACATCCGCAAAGAC3’(forward) and 5’-ATCAACG-
CAATGTGGGAAA-3’(reverse). Thermal cycling was
initiated with a denaturation step for 5 min at 94°C
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30 s at 58°C and 1 min at 72°C.
Cell proliferation assay
Cell proliferation was assessed using the CellTiter 96
Aqueous assay kit (Promega, Madison, WI). After trans-
fection, the cells (10,000/well) were seeded in 96-well
plates and incubated at 37°C, and cell proliferation was
assessed after 96 h based on the absorbance measured
at 570 nm using a multiwell spectrophotometer.
Flow cytometry
Apoptosis was evaluated by Annexin V-PE/7-AAD
staining followed by flow cytometry analysis. After cells
were plated in 6-well plates at a density of 1 × 10
5/well
and cultured at 37°C in 5% CO2 incubator for three
days, they were transfected with NSBP1 siRNA or
scramble siRNA vector, the cells were gently trypsinized
and washed with ice-cold PBS after 72 h. At least 20,000
cells were resuspended in 500 μL1×b i n d i n gb u f f e r ,
stained with 5 μL7 - A A D( 2 5μgm L
-1)a n d1μL
Annexin V-PE and immediately analyzed with a FACS-
calibur flow cytometer (Becton Dickinson, Erembode-
gem, Belgium).
Western blot analysis
inhibitors. Protein samples(40 ug)were separated in 10%
SDS-polyacrylamide gels and transferred to PVDF mem-
branes. The membranes were blocked with nonfat milk
in TBST, and probed with primary antibodies CyclinB1
(CST-4138), CyclinD1 (CST-2978), Proliferating Cell
Nuclear Antigen (PCNA, CST-2586), Bax (CST-2772),
Bcl-2 (CST-2876), VEGF (CST-2445), VEGFR-2 (CST-
2472), MMP-2 (CST-4022), MMP-9 (CST-3852) (CST
indicated Cell Signaling Technology, Beverly, MA, USA).
c-fos (santa cruz-52), c-jun (santa cruz-1694), GAPDH
(santa cruz-137179), or b-Actin (santa cruz-81178), and
secondary antibodies goat anti-mouse IgG (santa cruz),
goat anti-rabbit IgG (santa cruz) (santa cruz indicated
Santa Cruz Biotech, Santa Cruz, CA, USA). Immunor-
eactivity signals were developed using ECL kit (GE
Healthcare Bioscience, Piscataway, NJ, USA). protease
and phosphatase with Whole-cell extracts were prepared
in RIPA buffer
Cell invasion assay
Cell invasion assay was performed with 24-well Trans-
well insert (pore size 8 μm, Corning, NY). After trans-
fection, 786-O cells were starved in serum free medium
overnight, and 3-5 × 10
4 cells were resuspended in 200
ul serum-free medium and placed in the upper cham-
bers with 8 μm filter pores in triplicate. The membrane
u n d e r s u r f a c ew a sc o a t e dw i t h3 0u lE C Mg e lf r o m
Engelbreth-Holm-Swarm mouse sarcoma (BD
Biosciences, Bedford, MA, USA) mixed with RPMI-1640
serum free medium in 1:5 dilution for 30 min at 37°.
The lower chamber was filled with 500 ul 10% FBS as
the chemoattractant and incubated for 48 h. At the end
of the experiments, the cells on the upper surface of the
membrane were removed by cotton buds, and the cells
on the lower surfaPBS-buffered paraformaldehyde and
stained with 0.1% crystal violet. Five visual fields were
chosen randomly for each insert and photographed
under a light microscope at 200 × magnification. The
cells were counted and the data were summarized by
means ± standard deviation and presented by a percen-
tage of controls. ce of the insert were fixed in 4%.
Gelatin zymography assay
After transfection, the cells were cultured in serum free
medium for 24 h. Then the medium was collected by
centrifugation at 4,000 rpm for 15 min at 4°C, and sub-
jected to zymographic SDS-PAGE containing 0.1% gela-
tin (w/v). The gels were washed and incubated in
incubation buffer for 48 h, then stained with Coomassie
Brilliant Blue and destained. The zones of gelatinolytic
activity were shown by negative staining.
Tumourigenesis assay in nude mice
Female BALB/c
nu/numice (4-6 weeks old, weighed 25-30 g)
were maintained in a germ-free environment in the animal
facility. NSBP1 knockdown or control 786-O cells were
cultured in 100-mm dishes and trypsinized. The cells (10
6
in 100 ul medium) were infused subcutaneously in the
armpit area. Tumor diameter was measured every 5 days,
and tumor volume was calculated by length × width
2× 0.5.
Mice were sacrificed after 1.5 months.
Statistical analysis
Values were represented as mean ± SD for at least tri-
plicate determination, and analyzed using Fisher’se x a c t
test and Kruskal-Wallis test. All statistical analyses were
performed using SPSS 13.0 and P < 0.05 was considered
as statistically significant.
Results
NSBP1 expression is high in ccRCC tissues
We examined NSBP1 expression in ccRCC tissue by
immunohistochemistry. As shown in Figure 1A, NSBP1
staining was weak in the normal renal tissues but strong
in ccRCC tissues. Western blot analysis of 20 paired
adjacent normal renal tissues and ccRCC tissues con-
firmed the high expression of NSBP1 in ccRCC tissues
(p = 0.006) (Figure 1B). Most importantly, we found
that NSBP1 staining intensity was correlated with the
clinical and pathologic characteristics of ccRCC
(Table 1). NSBP1 expression was positively correlated
with the tumor grade and pathologic stage.
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We examined NSBP1 expression in ccRCC cell lines and
the normal renal tubular epithelial line cells by quantita-
tive real-time RT-PCR and Western blot. NSBP1 protein
level was higher in ccRCC cell lines than normal renal
tubular epithelial line cells (Figure 1C). Similarly, NSBP1
mRNA level was increased in ccRCC cell lines compared
to normal renal tubular epithelial line cells (Figure 1D).
NSBP1 knockdown decreases the proliferation of ccRCC
cells
To investigate the role of NSBP1 in the proliferation of
ccRCC cells, we employed the loss of function approach.
786-O cells were transfected with NSBP1 siRNA or
scramble siRNA as control and cell proliferation was
evaluated by MTT assay. The results showed that NSBP1
knockdown significantly reduced proliferation of ccRCC
cells over the 72 h period (Figure 2A). Lentivirus short
hairpin constructs against NSBP1 (PscSI616) was efficient
and specific in the knockdown of NSBP1 in 786-O cells
and the inhibitory efficiency at protein level was 74.8 ±
2.1% based on Western blot analysis (Figure 2C).
Figure 1 NSBP1 expression is high in ccRCC tissues and cells. (A), Representative immunohistochemistry staining of NSBP1 in control renal
tissue and ccRCC tissue. NSBP1 immunoreactivity in brown was predominantly localized in the nucleus. Original magnification: X10 (a, c), X40 (b,
d). (B) Ratio between protein expression levels of NSBP1 and b-Actin in pairs of ccRCC and normal tissue from 20 patients was calculated based
on Western blot analysis. (C), Western blots demonstrating the expression of NSBP1 in different ccRCC cells. Actin served as loading control. (D),
Real-time PCR assay showing the relative NSBP1 mRNA level in different ccRCC cells. *p < 0.05, **p < 0.01, versus HK-2 cells.
Table 1 Correlation of NSBP1 expression with clinical and
pathological characteristics of renal carcinoma
Characteristics Cases NSBP1 immunoreactivity P
-+ + +
Cases
(%)
Cases
(%)
Cases
(%)
Gender 0.653
Male 129 18 11.8 33 21.7 78 51.3
Female 23 3 2.0 8 5.3 12 7.9
Age (years) 60.4 ± 8.9 59.8 ±
9.7
60.2 ±
9.8
61.3 ± 11
Grade 0.040*
10 0 0 0
2 63 14 9.2 16 10.5 33 21.7
3 89 7 4.6 25 16.5 57 37.5
Pathologic stage 0.002**
T1 18 10 6.6 5 3.3 3 2.0
T2 35 6 3.9 12 7.9 17 11.1
T3 47 3 2.0 15 9.9 29 19.1
T4 52 2 1.3 9 5.9 41 27.0
Correlation significant at the 0.05 level (one-tailed)
*P < 0.05; **P < 0.01
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after the cells were transfected with NSBP1 siRNA or
scramble siRNA as control. The apoptotic ratio was
increased in NSBP1 knockdown 786-O cells compared
to control (Figure 2B). To confirm that NSBP1 knock-
down could inhibit proliferation and induce apoptosis in
ccRCC cells, we examined the expression of apoptosis
and cell cycle related proteins and found that Bax pro-
tein level was significantly increased while CyclinB1 and
Bcl-2 protein levels were decreased in NSBP1 knock-
down cells compared with control (Figure 2C). These
data provide evidence that NSBP1 modulates cell cycle
and antagonizes apoptosis to promote the oncogenic
potential of ccRCC cells.
NSBP1 knockdown inhibits the invasion of ccRCC cells
Next we assessed the role of NSBP1 in cell invasion, an
important aspect of ccRCC metastasis. By transwell
assay we found that NSBP1 knockdown cells showed
few number of invading cells compared to control
group which expressed high level of NSBP1 (Figure 3A).
The number of cells crossing the matrigel was 62.3 ±
3.1 in NSBP1 siRNA group versus 110.7 ± 3.1 in scram-
ble siRNA control group (P < 0.05). Moreover, gelatin
zymography assay demonstrated that NSBP1 knockdown
efficiently decreased MMP-2 and MMP-9 enzymatic
activity, especially MMP-9 enzymatic activity (Figure
3B). To address whether decreased MMP-9 and MMP-2
activity is due to the downreguation of their expression
after NSBP1 knockdown, we examined the expression of
MMP-9, MMP-2 and their upstream transcription fac-
tors c-fos and c-jun. Western blot analysis demonstrated
that NSBP1 knockdown downregulated the expression
of VEGF, VEGFR-2, MMP-2, MMP-9, c-fos and c-jun
(Figure 3C). Taken together, these data suggest that
NSBP1 upregulates the expression of MMP-2 and
MMP-9 via c-fos and c-jun. The increased MMPs activ-
ity and angiogenesis then contributes to the migration
and invasion of ccRCC cells.
NSBP1 knockdown inhibits ccRCC growth in xenograft
nude mice
To further investigate the role of NSBP1 in ccRCC in
vivo, we established xenograft ccRCC by subcutaneous
injection of 1 × 10
6 NSBP1 knockdown 786-O cells or
the corresponding scramble siRNA transfected control
cells into the flanks of BALB/c nude mice (n = 10).
After 6 weeks, we observed that the volume of tumor
derived from NSBP1 knockdown cells was significantly
smaller than that derived from control cells (Figure 4).
These data demonstrate that NSBP1 knockdown inhibits
the tumorigenicity of ccRCC cells in vivo.
Figure 2 NSBP1 knockdown decreases the proliferation of ccRCC cells. (A), MTT assay showing that NSBP1 knockdown significantly reduced
the proliferation of ccRCC cells over the 96 h period. (B), Annexin V-PE/7-AAD staining in FCM assays showing the ratio of apoptosis in different
786-O cells. (Data were presented as mean ± SEM, n = 3). (C), Representative blots demonstrating the reduced protein level of NSBP1 in NSBP1
siRNA transfected 786-O cells compared to scramble siRNA transfected cells. In addition, Bax protein level was increased and CyclinB1 and Bcl-2
levels were decreased in NSBP1 siRNA transfected 786-O cells compared to scramble siRNA transfected cells.
Ji et al. Journal of Experimental & Clinical Cancer Research 2012, 31:22
http://www.jeccr.com/content/31/1/22
Page 5 of 8Discussion
NSBP1 was identified as a new member of the HMGN
protein family in 2001 [12,13]. As a nuclear protein,
NSBP1 modulates the structure and function of chroma-
tin and plays an important role in transcription, DNA
replication and repair [14-16]. Interestingly, recent stu-
dies demonstrated that NSBP1 expression was abnor-
mally high in a variety of solid tumors, indicating the
oncogenic role of NSBP1 [4-7],
In this study, we found that NSBP1 expression was
significantly higher in ccRCC tissues and cell lines than
normal renal tissue and cell lines. These data suggest
that NSBP1 overexpression is correlated with the pro-
gression of ccRCC.
To elucidate the role of NSBP1 in the tumorigenesis of
ccRCC, we employed loss of function approach via the
knockdown of endogenous NSBP1 expression in ccRCC
cells. Notably, we found that NSBP1 knockdown inhib-
ited the proliferation rate of ccRCC cells through MTT
assay. Furthermore, our experiments showed that knock-
down of NSBP1 led to increased Bax expression and
decreased CyclinB1, Bcl-2 expression. These results sug-
gest that downregulation of NSBP1 expression causeds
G2 cell cycle arrest, decreases the proliferation rate and
increases apoptosis rate in ccRCC cells in vitro[17-20].
Metastasis is an important aspect of ccRCC. To charac-
terize the role of NSBP1 in ccRCC metastasis, we
employed in vitro invasion assay and found that NSBP1
Figure 3 NSBP1 knockdown inhibits the invasion of ccRCC cells. (A), Representative photos showing the invasion of ccRCC cells into the
lower chamber of transwell. ×200. (B), Gelatin zymography assay showing that MMP-9 and MMP-2 activities were decreased in NSBP1
knockdown 786-O cells. Data shown were mean ± SEM from three independent experiments. (C), Western blot analysis showing that the
expression of VEGF, VEGFR-2, MMP-2, MMP-9, c-fos and c-jun were significantly decreased in NSBP1 knockdown 786-O cells. Data shown were
mean ± SEM from three independent experiments. *p < 0.05, **p < 0.01, versus the scramble siRNA transfected control group.
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Tumor invasion and metastasis are crucially dependent on
MMPs and VEGF [10,11,20]. MMP-2 and MMP-9 play
important roles in the degradation of the ECM, including
type IV collagen, and their activity and expression are cor-
related with metastatic abilities and prognosis of cancer
[21,22]. Our results showed that silencing of NSBP1 in
786-O cells decreased MMP-2 and MMP-9 activity based
on zymography assay. In addition, we found that MMP-2
and MMP-9 expression as well as the expression of tran-
scription factors c-fos and c-jun were decreased in NSBP1
knockdown cells. These data suggest that NSBP1 modu-
lates the expression of MMPs and VEGF/VEGFR-2 thus
influencing the invasion behavior of ccRCC cells.
Finally, to demonstrate that NSBP1 contributes to
ccRCC development in vivo, we employed xenograft
nude mice model and found that NSBP1 knockdown
suppressed tumor growth of ccRCC cells, indicating
that NSBP1 promotes the tumorigenicity of ccRCC cells
in vivo.
In summary, here we present both in vitro and in vivo
evidence that NSBP1 promotes ccRCC cells growth and
invasion. NSBP1 plays important role in the regulation
of apoptosis and invasion of ccRCC cells by regulating
the expression of Bcl-2, Bax, CyclinB1 VEGF/VEGFR-2
and MMPs. Based on these findings, intervention with
NSBP1 expression may provide a therapeutic approach
in ccRCC development and metastasis.
Figure 4 NSBP1 knockdown inhibits the tumorigenicity of ccRCC cells in vivo. (A), A representative nude mice showing the different
morphology of the tumors derived from NSBP1 siRNA transfected 786-O cells (left side) and scramble siRNA transfected control cells (right side).
(B), the growth curve of the tumors (n = 10).
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